Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA) is a condition characterized by involuntary pauses in breathing during sleep, caused by the narrowing of the airway in the throat. This interruption in airflow leads to snoring and disrupted sleep patterns, resulting in daytime drowsiness and cognitive impairment. OSA is most common among older individuals and those who are overweight. Weight loss often improves symptoms.
Diagnosis involves a comprehensive history, physical examination, and questionnaire regarding daytime drowsiness and sleep quality. During sleep, relaxation of throat muscles causes the airway to narrow or close, reducing oxygen levels in the blood. Treatment options include lifestyle changes, such as avoiding sleeping on the back, and medical interventions like continuous positive airway pressure (CPAP) therapy. Early detection and management are crucial to prevent complications and improve overall quality of life.
- What are the types of Obstructive sleep apnea?
- What Causes Obstructive sleep apnea?
- What Are the Signs & Symptoms of Obstructive sleep apnea?
- How Is Obstructive sleep apnea Diagnosed?
- How Is Obstructive sleep apnea Treat?
Related Conference of Obstructive Sleep Apnea
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
16th International Conference on Chronic Obstructive Pulmonary Disease
Obstructive Sleep Apnea Conference Speakers
Recommended Sessions
- Advancements in Pulmonary Diagnostics
- Cardio Pulmonary Disorders
- Chronic Obstructive Pulmonary Disease
- COVID-19 and Asthma
- COVID-19 and Respiratory System
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung Cancer
- Lung Transplantation
- Obstructive Sleep Apnea
- Occupational Lung Diseases
- Pneumonia
- Pulmonary diseases: Treatment, Diagnosis and therapies
- Pulmonary Hypertension
- Pulmonary Rehabilitation
- Tuberculosis
Related Journals
Are you interested in
- Asthma - Tuberculosis-2024 (France)
- Asthma and Allergy - COPD CONGRESS 2024 (UK)
- Asthma and COPD - COPD_2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - COPD CONGRESS 2024 (UK)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic bronchitis - COPD CONGRESS 2024 (UK)
- Chronic Obstructive Pulmonary Disease - COPD_2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- Co-Morbidities of COPD - COPD_2024 (France)
- COPD and Air Pollution - COPD CONGRESS 2024 (UK)
- COPD and Cardiovascular Diseases - COPD_2024 (France)
- COPD Complications - COPD_2024 (France)
- COPD Exacerbations - COPD_2024 (France)
- COPD Pathogenesis - COPD_2024 (France)
- COPD Pathogenesis - COPD CONGRESS 2024 (UK)
- COPD Therapeutics - COPD_2024 (France)
- COPD-Chronic obstructive pulmonary disease - COPD CONGRESS 2024 (UK)
- COPD: Sign and Symptoms - COPD_2024 (France)
- Depression and Anxiety in COPD - COPD CONGRESS 2024 (UK)
- Depression and anxiety in COPD - COPD_2024 (France)
- Diagnosis and Treatment of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD CONGRESS 2024 (UK)
- Drug Discovery of COPD - COPD_2024 (France)
- Effect of COVID-19 on Lungs - COPD CONGRESS 2024 (UK)
- Emphysema - COPD CONGRESS 2024 (UK)
- Epidemiology of COPD - COPD_2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetic risk factor of COPD - COPD_2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung cancer - COPD_2024 (France)
- Lung cancer - COPD CONGRESS 2024 (UK)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - COPD CONGRESS 2024 (UK)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - COPD CONGRESS 2024 (UK)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pathophysiology of COPD - COPD_2024 (France)
- Pediatric Neonatal Care in COPD - COPD CONGRESS 2024 (UK)
- Pediatric Pulmonary, Critical care and Sleep - COPD_2024 (France)
- Pediatric Pulmonology & Critical care - COPD CONGRESS 2024 (UK)
- Prevention of COPD - COPD CONGRESS 2024 (UK)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary diseases - COPD CONGRESS 2024 (UK)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases-treatment and therapies - COPD_2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - COPD_2024 (France)
- Pulmonary Rehabilitation - COPD CONGRESS 2024 (UK)
- Respiratory and sleep Medicine - COPD CONGRESS 2024 (UK)
- Respiratory Failure and COPD Complications: - COPD CONGRESS 2024 (UK)
- Respiratory Tract Infections - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD CONGRESS 2024 (UK)
- Self-Management and Prevention of COPD - COPD_2024 (France)
- Spirometry - COPD CONGRESS 2024 (UK)
- Stages & Severity on Lung Diseases - COPD CONGRESS 2024 (UK)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tobacco control - COPD CONGRESS 2024 (UK)
- Types of COPD - COPD_2024 (France)
- Types of COPD - COPD CONGRESS 2024 (UK)
- Zoonotic TB - Tuberculosis-2024 (France)